Merrimack to scrap development of pancreatic cancer treatment

(Reuters) - Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main and secondary goals in a mid-stage trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news